Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.
Levine, John E
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy. [electronic resource] - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Mar 2003 - 189-97 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
1083-8791
10.1053/bbmt.2003.50012 doi
Acute Disease
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Busulfan--administration & dosage
Graft vs Host Disease--chemically induced
Hematologic Neoplasms--complications
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Middle Aged
Mycophenolic Acid--administration & dosage
Radiotherapy, Adjuvant
Survival Analysis
Transplantation Conditioning--methods
Transplantation, Homologous
Treatment Outcome
Vidarabine--administration & dosage
Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy. [electronic resource] - Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation Mar 2003 - 189-97 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.
1083-8791
10.1053/bbmt.2003.50012 doi
Acute Disease
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Busulfan--administration & dosage
Graft vs Host Disease--chemically induced
Hematologic Neoplasms--complications
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Middle Aged
Mycophenolic Acid--administration & dosage
Radiotherapy, Adjuvant
Survival Analysis
Transplantation Conditioning--methods
Transplantation, Homologous
Treatment Outcome
Vidarabine--administration & dosage